These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 8306923

  • 1. [Comparative double-blind study of bromazepam versus prazepam in non-psychotic anxiety].
    Guelfi JD, Lancrenon S, Millet V.
    Encephale; 1993; 19(5):547-52. PubMed ID: 8306923
    [Abstract] [Full Text] [Related]

  • 2. [Comparison of 6 different methods for lorazepam withdrawal. A controlled study, hydroxyzine versus placebo].
    Lemoine P, Touchon J, Billardon M.
    Encephale; 1997; 23(4):290-9. PubMed ID: 9417395
    [Abstract] [Full Text] [Related]

  • 3. [Efficacy and tolerance of alprazolam and bromazepam in flexible doses. Double-blind study in 119 ambulatory anxious patients].
    Ropert R, Bernes J, Dachary JM.
    Encephale; 1987; 13(2):89-95. PubMed ID: 2885173
    [Abstract] [Full Text] [Related]

  • 4. [Treatment of anxiety with prazepam, 40 mg. A controlled study versus lorazepam].
    Danion JM, Brion S, Escande M, Ropert R, Sacquepee L, Singer L, Scotto JC.
    Encephale; 1984; 10(3):135-8. PubMed ID: 6389091
    [Abstract] [Full Text] [Related]

  • 5. Double-blind, comparative study of cyamemazine vs. bromazepam in the benzodiazepine withdrawal syndrome.
    Lemoine P, Kermadi I, Garcia-Acosta S, Garay RP, Dib M.
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jan; 30(1):131-7. PubMed ID: 16243418
    [Abstract] [Full Text] [Related]

  • 6. Deramciclane in the treatment of generalized anxiety disorder: a placebo-controlled, double-blind, dose-finding study.
    Naukkarinen H, Raassina R, Penttinen J, Ahokas A, Jokinen R, Koponen H, Lepola U, Kanerva H, Lehtonen L, Pohjalainen T, Partanen A, Mäki-Ikola O, Rouru J, Deramciclane Dose-Finding Study Group.
    Eur Neuropsychopharmacol; 2005 Dec; 15(6):617-23. PubMed ID: 15949921
    [Abstract] [Full Text] [Related]

  • 7. [Prazepam drops versus 10 mg prazepam tablets in anxious patients in ambulatory care].
    Chabannes JP, Lemoine P.
    Therapie; 1990 Dec; 45(6):467-70. PubMed ID: 2080484
    [Abstract] [Full Text] [Related]

  • 8. A multi-centre comparison of prazepam and diazepam in the treatment of anxiety.
    Dorman T.
    Pharmatherapeutica; 1983 Dec; 3(6):433-40. PubMed ID: 6353434
    [Abstract] [Full Text] [Related]

  • 9. Bromazepam, a new anxiolytic: a comparative study with diazepam in general practice. Royal College of General Practitioners Medicines Surveillance Organisation.
    Royal College of General Practitioners Medicines Surveillance Organisation.
    J R Coll Gen Pract; 1984 Sep; 34(266):509-12. PubMed ID: 6147412
    [Abstract] [Full Text] [Related]

  • 10. [Modification of cognitive functions by 2 anxiolytic treatments in patients suffering from generalized anxiety].
    Samuelian JC, Billardon M, Guillou N.
    Encephale; 1995 Sep; 21(2):147-53. PubMed ID: 7781586
    [Abstract] [Full Text] [Related]

  • 11. [alpha-beta L-aspartate magnesium in treatment of chronic benzodiazepine abuse: controlled and double-blind study versus placebo].
    Hantouche EG, Guelfi JD, Comet D.
    Encephale; 1998 Sep; 24(5):469-79. PubMed ID: 9850822
    [Abstract] [Full Text] [Related]

  • 12. [Value of prazepam drops in the brief treatment of anxiety disorders].
    Ansseau M, Von Frenckell R.
    Encephale; 1991 Sep; 17(4):291-4. PubMed ID: 1959497
    [Abstract] [Full Text] [Related]

  • 13. Bromazepam and diazepam in generalized anxiety: a placebo-controlled study with measurement of drug plasma concentrations.
    Fontaine R, Annable L, Chouinard G, Ogilvie RI.
    J Clin Psychopharmacol; 1983 Apr; 3(2):80-7. PubMed ID: 6132936
    [Abstract] [Full Text] [Related]

  • 14. Bromazepam ('Lexotanil') compared with placebo: a double-blind, crossover study.
    Rey A, Bovet J, Schneider PB.
    Pharmatherapeutica; 1984 Apr; 4(1):13-20. PubMed ID: 6150491
    [Abstract] [Full Text] [Related]

  • 15. [Value of hydroxyzine in generalized anxiety disorder: controlled double-blind study versus placebo].
    Ferreri M, Hantouche EG, Billardon M.
    Encephale; 1994 Apr; 20(6):785-91. PubMed ID: 7875114
    [Abstract] [Full Text] [Related]

  • 16. [Clinical study of bromazepam. Thirty cases (author's transl)].
    Sechter D, Petitjean F, Bitoun G.
    Nouv Presse Med; 1982 May 13; 11(22):1744-6. PubMed ID: 6124949
    [Abstract] [Full Text] [Related]

  • 17. Experimental comparison of low doses of 1.5 mg fluspirilene and bromazepam in out-patients with psychovegetative disturbances.
    Hassel P.
    Pharmacopsychiatry; 1985 Sep 13; 18(5):297-302. PubMed ID: 2864709
    [Abstract] [Full Text] [Related]

  • 18. The role of captodiamine in the withdrawal from long-term benzodiazepine treatment.
    Mercier-Guyon C, Chabannes JP, Saviuc P.
    Curr Med Res Opin; 2004 Sep 13; 20(9):1347-55. PubMed ID: 15383182
    [Abstract] [Full Text] [Related]

  • 19. [Clinical trial of bromazepam. Thirty-four cases (author's transl)].
    Horseau C, Brion S.
    Nouv Presse Med; 1982 May 13; 11(22):1741-3. PubMed ID: 6124948
    [Abstract] [Full Text] [Related]

  • 20. [Anxiety in ambulatory and hospital practice: effects of a new anxiolytic agent, bromazepam, in a homogeneous series of 30 patients (author's transl)].
    Billé J, Dalmas C.
    Nouv Presse Med; 1982 May 13; 11(22):1706-9. PubMed ID: 6124938
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.